STOCKHOLM, Sweden–Regulatory News: Biotage AB (STO:BIOTA) has together with its subsidiaries Biotage GB Ltd and Biotage LLC been sued for patent infringement in the U.S. District court for the Southern District of California. The lawsuit has been filed by Scientific Plastic Products, Inc. and concerns the US patents no 7,138,061, 7,381,327 and 7,410,571 each entitled ”Flash Chromatography Cartridge”. The law suit concerns Biotage’s sale of the product line SNAP in the US. “In our business there are continuous discussions about and challenge of patents. It is yet too early for us to give a firm opinion on the status of this matter. Our initial analysis does indicate that we have a strong position, though, and that the plaintiff does not have good cause for the alleged patent infringement.”, says Torben Jørgensen, CEO, Biotage AB.

About Biotage

Biotage is a global company active in life science research with strong technologies, a broad range of operations and a long-term view of the market. The company offers solutions, knowledge and experience in the area of medicinal chemistry. In 2005 business and products from the company Argonaut were acquired, further strengthening the product range in medicinal chemistry. The customers include the worlds top 30 pharma companies, the worlds top 20 biotech companies, and leading academic institutes. The company is headquartered in Uppsala and has subsidiaries in the U.S., Japan, UK, Germany and several other European countries. Biotage has 300 employees and had sales of SEK 385,3m in 2008. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website: www.biotage.com

This information was brought to you by Cision https://www.cisionwire.com